decreased sensitivity to induced morbidity/mortality_Eef2<tm1.1Lepp>/Eef2<+>

http://metadb.riken.jp/0009764IC57BL6Eef2tm11LeppEef2Eef2tm11LeppEef2

decreased sensitivity to induced morbidity/mortality_Eef2<tm1.1Lepp>/Eef2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• eukaryotic translation elongation factor 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:95288

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Eef2<tm1.1Lepp>/Eef2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Eef2<tm1.1Lepp>|Eef2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009764

文献

http://purl.org/net/cito/citesAsAuthority

• Shihui. Liu, et.al., Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development., Proceedings of the National Academy of Sciences of the United States of America, 2012, 109
  http://rdf.ncbi.nlm.nih.gov/pubmed/22869748